Search Results 661-670 of 17106 for egfr

1. Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D) - Mayo Clinic

   The purpose of this multi-center event-driven study in participants with anemia associated with chronic kidney disease (CKD) to evaluate the safety and efficacy ...

2. A Study of REGN2810 and Ipilimumab in Patients With Lung Cancer - Mayo Clinic

   Patients with tumors tested positive for epidermal growth factor receptor (EGFR) gene mutations, anaplastic lymphoma kinase (ALK) gene translocations, or C-ros ...

3. Study Of RYZ101 Compared With SOC In Pts W Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy - Mayo Clinic

   Adequate renal function, as evidenced by estimated glomerular filtration rate (eGFR) ≥60 mL/min/1.73 m2 (calculated using the Chronic Kidney Disease ...

4. A Study of Sonidegib and Pembrolizumab in Advanced Solid Tumors - Mayo Clinic

   Patients with EGFR, ALK, or BRAF genomic abnormalities must have also received and progressed on prior FDA-approved targeted therapies. Melanoma ...

5. LUPKYNIS US Registry Trial - Mayo Clinic

   serum creatinine and/or eGFR;; Have access to US healthcare insurance;; Ability to understand and provide written informed consent. Exclusion Criteria: Off ...

6. LEVosimendan To Improve Exercise Limitation In Patients With PH-HFpEF - Mayo Clinic

   Body mass index greater than or equal to 50 kg/m^2. 14. Estimated glomerular filtration rate (eGFR) < 30 mL/min/1.73m^2 15. Known history of chronic liver ...

7. Polycystic kidney disease - Doctors and departments - Mayo Clinic

   Learn how treatments and lifestyle changes might help reduce kidney damage from this disease.

8. DSC-MRI in Measuring Relative Cerebral Blood Volume for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma - Mayo Clinic

   ... (eGFR) >= 40 mL/min/1.73 m^2 as calculated per institution standard of care, and meeting local site requirements for intravenous administration of gadolinium ...

9. A Study to Evaluate Immunotherapy for Non-Small Cell Lung Cancer - Mayo Clinic

   NSCLC expressing epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), B-Raf proto-oncogene (BRAF) or ROS proto-oncogene 1 (ROS1) ...

10. Adjunctive Ganaxolone (GNX) Treatment in Children and Adults with Tuberous Sclerosis Complex (TSC)-related Epilepsy (TrustTSC) - Mayo Clinic

    Patients with significant renal insufficiency, estimated glomerular filtration rate (eGFR) < 30 mL/min (calculated using the Cockcroft-Gault formula or ...